The 100,000 genomes project is central to the NHS England Personalised Medicine Strategy – this aims to move treatment from a ‘one size fits all’ approach to one where personalised therapies are selected on the basis of each patient’s genetic data.

The national plan is to collect information from germline and tumour genomes from 20,000 patients with cancer (40,000 genomes in total), along with 60,000 genomes from patients with non-cancerous ‘rare diseases’, by the end of 2018.

The first newsletter on the cancer part of the project in Greater Manchester has now been published.